Alexion Pharmaceuticals, Inc.
DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF GENERALIZED MYASTHENIA GRAVIS
Last updated:
Abstract:
Provided are methods for clinical treatment of generalized myasthenia gravis (gMG) using an anti-C5 antibody or antigen binding fragment thereof.
Status:
Application
Type:
Utility
Filling date:
14 Feb 2020
Issue date:
22 Oct 2020